Daniel Thomas O 4
4 · Gossamer Bio, Inc. · Filed Feb 12, 2019
Insider Transaction Report
Form 4
Daniel Thomas O
Director
Transactions
- Conversion
Series A Preferred Stock
2019-02-12−171,429→ 0 total(indirect: By Trust)→ Common Stock (38,095 underlying) - Conversion
Common Stock
2019-02-12+38,095→ 38,095 total(indirect: By Trust)
Footnotes (1)
- [F1]The shares of the Issuer's Series A Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 4.5 to one share, immediately prior to the consummation of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date.